CClinicalTrials.gg
RecruitingNCT05760885MABUpdated Jan 6, 2026

Multisensory Augmentation for Post-stroke Standing Balance

An Early Phase 1 interventional study of Balance training with sensory augmentation and Balance training in Stroke, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by VA Office of Research and Development · Early Phase 1, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 8 months later.
Phase
Early Phase 1
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Many individuals who experience a stroke have problems with their balance. In part, these balance problems may be due to sensory issues. This study will test whether sensory augmentation has the potential to improve post-stroke balance. Sensory augmentation is a method by which non-invasive vibration is used to enhance the sensory information available to users, which may make it easier to feel where they are and prevent losses of balance.

Read the detailed description

The objective of this study is to design a novel multisensory augmentation approach to improve the control of standing balance in people with chronic stroke. With sensory augmentation, artificial feedback provides the nervous system with information about the dynamic state of the body, which can be used to prevent losses of balance. This clinical trial will investigate whether multisensory augmentation produces sustained balance improvements when applied as a training device. These potential improvements will be assessed by comparing the results of clinical and biomechanical assessments before and after a 10-week balance training program, in which half of the participants will be randomly assigned sensory augmentation.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 36 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age of at least 21 years;
  2. Experience of a stroke at least 6 months prior to participation;
  3. Berg Balance Scale score less than 52
  4. Ability to stand independently for at least 1 minute without wearing an AFO or other brace that would preclude delivery of stimulation to the ankle or foot sole
  5. Provision of informed consent

Exclusion criteria

Exclusion Criteria:

  1. Resting blood pressure higher than 220/110 mm Hg
  2. History of unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living
  3. Pre-existing neurological disorders or dementia
  4. Severe visual impairment
  5. History of DVT or pulmonary embolism within 6 months
  6. Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Sensory Augmentation

    Participants will receive sensory augmentation in the form of non-invasive vibration, while balance training is performed as described below.

    Behavioral: Balance training with sensory augmentation

  • Active comparator
    Control

    Participants will receive balance training, without any sensory augmentation.

    Behavioral: Balance training

Interventions

  • BehavioralBalance training with sensory augmentation

    Participants will complete 20 balance training sessions, in which they are required to keep their balance while standing on a platform that translates under their feet. During training, sensory augmentation will be delivered with an intensity controlled in real-time by their center of pressure motion. The difficulty of the balance training task will progressively increase over successive training sessions.

  • BehavioralBalance training

    Participants will complete 20 balance training sessions, in which they are required to keep their balance while standing on a platform that translates under their feet. During training, no sensory stimulation will be delivered. The difficulty of the balance training task will progressively increase over successive training sessions.

06

What researchers measure

Primary outcomes

  1. Berg Balance Scale score change

    A standard clinical assessment to measure balance performance during various functional tasks

    Time frame: Before and after a 10-week period of balance training

Secondary outcomes

  1. Limits of Stability score (paretic direction)

    A standard assessment of how far participants are willing and able to shift their weight toward the paretic leg while standing

    Time frame: Before and after a 10-week period of balance training

  2. Limits of Stability score (non-paretic direction)

    A standard assessment of how far participants are willing and able to shift their weight toward the non-paretic leg while standing

    Time frame: Before and after a 10-week period of balance training

  3. Mediolateral center of pressure displacement

    A measure of sideways sway, which will be quantified as participants stand on a platform that translates sideways, challenging participant balance

    Time frame: Before and after a 10-week period of balance training

  4. Mediolateral center of pressure velocity

    A measure of sideways sway, which will be quantified as participants stand on a platform that translates sideways, challenging participant balance

    Time frame: Before and after a 10-week period of balance training

07

Study locations

1 of 1 sites recruiting
  • Ralph H. Johnson VA Medical Center, Charleston, SC
    Charleston, South Carolina 29401-5703, United States
    • Jesse C Dean, PhD · Contact · Jesse.Dean@va.gov · 843-792-9566
    • Aaron E Embry, DPT · Contact · Aaron.Embry@va.gov · (843) 792-8198
    • Jesse C. Dean, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — We plan to share de-identified data that contains no protected participant information. This data will be shared in the form of pre-prints and through online servers upon study results publication.

Supporting information: Study protocol, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05760885
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Mar 8, 2023
Start date
Jan 14, 2025
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Jan 6, 2026

Study contacts

Jesse C Dean, PhD
Contact
Jesse.Dean@va.gov
(843) 792-9566
Aaron E Embry, DPT
Contact
Aaron.Embry@va.gov
(843) 792-8198
Jesse C. Dean, PhD
principal investigator · Ralph H. Johnson VA Medical Center, Charleston, SC

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion